Pralsetinib (Pralsetinib) hospital supply and inventory situation in various regions in 2025

The supply situation of Pralsetinib (Pralsetinib) in 2025 shows certain differences in hospitals in various regions in the country. Some large tertiary hospitals in first-tier cities such as Beijing, Shanghai and Guangzhou have relatively sufficient stocks of platinib due to the large number of patients. However, due to the high drug prices, the actual quantity available for patients to purchase is still limited. Hospitals usually make limited allocations based on clinical needs and procurement plans to ensure that patients with clear indications are given priority.

In hospitals in second- and third-tier cities and remote areas, the supply of platinib is relatively tight, and some hospitals even need to make an appointment in advance or go through a specific pharmacy to obtain the drug. This is mainly because medicines are not included in medical insurance, patients’ purchases are limited, and the logistics and distribution cycle is long, making inventory updates slower than in first-tier cities. The hospital will flexibly adjust inventory allocation based on local patient needs and supply chain conditions to reduce the risk of drug shortages.

In overseas markets, the supply of platinib is generally stable, but the price fluctuates greatly. In regions such as the United States, Europe, and Japan where original drugs are marketed, due to mature procurement channels and sufficient inventory, the price of a box of 60 pills is usually between 40,000 and 100,000 yuan, and patients can obtain drugs through regular hospitals or pharmacies. The overseas generic drug market, such as 120 capsules produced in Laos, is priced at more than 3,000 yuan, providing an option for patients with limited budgets, but they still need to purchase through reliable channels to ensure drug quality.

Overall, hospital supply and inventory of Platinib in different regions around the world are affected by a variety of factors, including drug pricing, medical insurance policies, logistics and patient demand. Domestic patients should consult the hospital pharmacy inventory in advance when purchasing, and understand the legality and reliability of overseas procurement channels to ensure that they can obtain the required drugs in a timely and stable manner.

Reference materials:https://www.drugs.com/